Epitheloid haemagioenthelioma in patient with liver transplantation (CROSBI ID 162715)
Prilog u časopisu | stručni rad
Podaci o odgovornosti
Filipec Kanižaj, Tajana ; Čolić-Cvrlje, Vesna ; Mrzljak, Anna ; Kardum-Skelin, Ika ; Šusterčić, Dunja ; Škegro, Dinko ; Guštin, Denis ; Kocman, Branislav
engleski
Epitheloid haemagioenthelioma in patient with liver transplantation
Malignant hepatic epithelioid hemangioendothelioma (HEH) is a rare malignant tumor of vascular origin with unknown aetiology and a variable natural course. At the time of diagnosis, most patients present with multifocal tumours lesions that involve both liver lobes. From the therapeutic aspect, liver resection (LRx), liver transplantation (LTx), chemotherapy, radiotherapy, and/or immunotherapy have been used in the treatment of patients with HEH. However, because of the rarity of this tumor and its unpredictable natural history, it is impossible to assess the effectiveness of these respective therapies. In this report, our objective was to present clinical aspects, diagnostic options, therapeutic modalities, and the clinical outcome of single patient with LTx because of this rare tumor.
hepatic epiteloid haemagioendothelioma; liver transplantation; fine needle aspiration cytology
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o izdanju
Povezanost rada
Kliničke medicinske znanosti